Virtual Reality exposure therapy for public speaking anxiety in routine care: a single-subject effectiveness trial

Virtual Reality (VR) can be used as a therapeutic tool to conduct efficacious in-session exposure therapy by presenting virtual equivalents of phobic stimuli, yet past hardware restrictions hindered implementation in routine care and effectiveness studies. The current study examines the effectivenes...

Full description

Saved in:
Bibliographic Details
Published inCognitive behaviour therapy Vol. 50; no. 1; pp. 67 - 87
Main Authors Lindner, Philip, Dagöö, Jesper, Hamilton, William, Miloff, Alexander, Andersson, Gerhard, Schill, Andreas, Carlbring, Per
Format Journal Article
LanguageEnglish
Published England Routledge 2021
Taylor & Francis Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Virtual Reality (VR) can be used as a therapeutic tool to conduct efficacious in-session exposure therapy by presenting virtual equivalents of phobic stimuli, yet past hardware restrictions hindered implementation in routine care and effectiveness studies. The current study examines the effectiveness of a VR-assisted treatment protocol for public speaking anxiety with demonstrated efficacy, this time in routine care, using affordable VR hardware. Participants (n = 23) were recruited via a private clinic and treated by one of four psychologists with only minimal VR-training. Using a single-subject design and dual-slope modeling (adjusting the treatment-onset slope for treatment effects), we found a significant, large decrease in self-rated public speaking anxiety following the primary three-hour session, similar in magnitude to the previous efficacy trial. Multilevel modeling of in-session process measures suggests that the protocol works as intended, by decreasing catastrophic belief expectancy and distress, and increasing perceived performance quality. Adherence to the online transition program that followed-encouraging in-vivo exposure-was relatively poor, yet symptoms decrease continued. No change was observed over the three-month follow-up period. We conclude that VR exposure therapy can be effective under routine care conditions and is an attractive approach for future, large-scale implementation and effectiveness trials.
AbstractList Virtual Reality (VR) can be used as a therapeutic tool to conduct efficacious in-session exposure therapy by presenting virtual equivalents of phobic stimuli, yet past hardware restrictions hindered implementation in routine care and effectiveness studies. The current study examines the effectiveness of a VR-assisted treatment protocol for public speaking anxiety with demonstrated efficacy, this time in routine care, using affordable VR hardware. Participants (n = 23) were recruited via a private clinic and treated by one of four psychologists with only minimal VR-training. Using a single-subject design and dual-slope modeling (adjusting the treatment-onset slope for treatment effects), we found a significant, large decrease in self-rated public speaking anxiety following the primary three-hour session, similar in magnitude to the previous efficacy trial. Multilevel modeling of in-session process measures suggests that the protocol works as intended, by decreasing catastrophic belief expectancy and distress, and increasing perceived performance quality. Adherence to the online transition program that followed-encouraging in-vivo exposure-was relatively poor, yet symptoms decrease continued. No change was observed over the three-month follow-up period. We conclude that VR exposure therapy can be effective under routine care conditions and is an attractive approach for future, large-scale implementation and effectiveness trials.
Virtual Reality (VR) can be used as a therapeutic tool to conduct efficacious in-session exposure therapy by presenting virtual equivalents of phobic stimuli, yet past hardware restrictions hindered implementation in routine care and effectiveness studies. The current study examines the effectiveness of a VR-assisted treatment protocol for public speaking anxiety with demonstrated efficacy, this time in routine care, using affordable VR hardware. Participants (n = 23) were recruited via a private clinic and treated by one of four psychologists with only minimal VR-training. Using a single-subject design and dual-slope modeling (adjusting the treatment-onset slope for treatment effects), we found a significant, large decrease in self-rated public speaking anxiety following the primary three-hour session, similar in magnitude to the previous efficacy trial. Multilevel modeling of in-session process measures suggests that the protocol works as intended, by decreasing catastrophic belief expectancy and distress, and increasing perceived performance quality. Adherence to the online transition program that followed-encouraging in-vivo exposure-was relatively poor, yet symptoms decrease continued. No change was observed over the three-month follow-up period. We conclude that VR exposure therapy can be effective under routine care conditions and is an attractive approach for future, large-scale implementation and effectiveness trials.Virtual Reality (VR) can be used as a therapeutic tool to conduct efficacious in-session exposure therapy by presenting virtual equivalents of phobic stimuli, yet past hardware restrictions hindered implementation in routine care and effectiveness studies. The current study examines the effectiveness of a VR-assisted treatment protocol for public speaking anxiety with demonstrated efficacy, this time in routine care, using affordable VR hardware. Participants (n = 23) were recruited via a private clinic and treated by one of four psychologists with only minimal VR-training. Using a single-subject design and dual-slope modeling (adjusting the treatment-onset slope for treatment effects), we found a significant, large decrease in self-rated public speaking anxiety following the primary three-hour session, similar in magnitude to the previous efficacy trial. Multilevel modeling of in-session process measures suggests that the protocol works as intended, by decreasing catastrophic belief expectancy and distress, and increasing perceived performance quality. Adherence to the online transition program that followed-encouraging in-vivo exposure-was relatively poor, yet symptoms decrease continued. No change was observed over the three-month follow-up period. We conclude that VR exposure therapy can be effective under routine care conditions and is an attractive approach for future, large-scale implementation and effectiveness trials.
Virtual Reality (VR) can be used as a therapeutic tool to conduct efficacious in-session exposure therapy by presenting virtual equivalents of phobic stimuli, yet past hardware restrictions hindered implementation in routine care and effectiveness studies. The current study examines the effectiveness of a VR-assisted treatment protocol for public speaking anxiety with demonstrated efficacy, this time in routine care, using affordable VR hardware. Participants (n = 23) were recruited via a private clinic and treated by one of four psychologists with only minimal VR-training. Using a single-subject design and dual-slope modeling (adjusting the treatment-onset slope for treatment effects), we found a significant, large decrease in self-rated public speaking anxiety following the primary three-hour session, similar in magnitude to the previous efficacy trial. Multilevel modeling of in-session process measures suggests that the protocol works as intended, by decreasing catastrophic belief expectancy and distress, and increasing perceived performance quality. Adherence to the online transition program that followed-encouraging in-vivo exposure-was relatively poor, yet symptoms decrease continued. No change was observed over the three-month follow-up period. We conclude that VR exposure therapy can be effective under routine care conditions and is an attractive approach for future, large-scale implementation and effectiveness trials.
Author Lindner, Philip
Andersson, Gerhard
Hamilton, William
Miloff, Alexander
Schill, Andreas
Carlbring, Per
Dagöö, Jesper
Author_xml – sequence: 1
  givenname: Philip
  orcidid: 0000-0002-3061-501X
  surname: Lindner
  fullname: Lindner, Philip
  email: philip.lindner@ki.se
  organization: Karolinska Institutet, & Stockholm Health Care Services
– sequence: 2
  givenname: Jesper
  orcidid: 0000-0001-5879-2168
  surname: Dagöö
  fullname: Dagöö, Jesper
  organization: PBM
– sequence: 3
  givenname: William
  orcidid: 0000-0003-0482-9521
  surname: Hamilton
  fullname: Hamilton, William
– sequence: 4
  givenname: Alexander
  orcidid: 0000-0002-9125-8060
  surname: Miloff
  fullname: Miloff, Alexander
  organization: Stockholm University
– sequence: 5
  givenname: Gerhard
  orcidid: 0000-0003-4753-6745
  surname: Andersson
  fullname: Andersson, Gerhard
  organization: Linköping University
– sequence: 6
  givenname: Andreas
  orcidid: 0000-0002-5136-212X
  surname: Schill
  fullname: Schill, Andreas
  organization: PBM
– sequence: 7
  givenname: Per
  orcidid: 0000-0002-2172-8813
  surname: Carlbring
  fullname: Carlbring, Per
  organization: Stockholm University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32870126$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-170067$$DView record from Swedish Publication Index
https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-186245$$DView record from Swedish Publication Index
http://kipublications.ki.se/Default.aspx?queryparsed=id:144557803$$DView record from Swedish Publication Index
BookMark eNqFkk1v1DAQhi1URNuFnwCyxIUDKY4_4gQuVOVTqoSEql4tx5kUb712aju0--_xsts9VKKcPJ553tHY8x6jAx88IPSyJic1acm7uhGkIZKdUEJLSnaCcvIEHZV8XVFWNwd_Y1JtoEN0nNKSFLLl9Bk6ZLSVpKbNEYqXNuZZO_wTtLN5jeFuCmmOgPMviHpa4zFEPM29swanCfS19VdY-zsLBbYexzBn6wEbHeE91jiVuoMqzf0STMYwjuWwv8FDSjhHq91z9HTULsGL3blAF18-X5x9q85_fP1-dnpeGSF4rgyMopHMAB86DXVjxlYaLfUoJZNdz8TQDLotN-gBOt4JXko9lYZQIHXHFqjatk23UOZXU7QrHdcqaKt2qesSgeJNKygr_Nt_8p_s5akK8UqlWdVtQ7l4tP0ed7bwkpDyjgV6s-WnGG5mSFmtbDLgnPYQ5qQoZ13DSFlWQV8_QJdhjr78VaFkIzgvuyvUqx019ysY9gPc77YAYguYGFKKMO6RmqiNh9S9h9TGQ2rnoaL78EBnbNbZBp-jtu6_6o9btfXFOSt9G6IbVNZrF-IYtTc2KfZ4iz9nWeEr
CitedBy_id crossref_primary_10_3390_electronics13173358
crossref_primary_10_3389_fpsyg_2022_972671
crossref_primary_10_1007_s11042_023_16917_2
crossref_primary_10_3389_fcomm_2022_910952
crossref_primary_10_1016_j_biopsycho_2022_108432
crossref_primary_10_1007_s12144_025_07376_z
crossref_primary_10_1007_s41811_020_00090_7
crossref_primary_10_12845_sft_64_2_2024_3
crossref_primary_10_1016_j_brat_2025_104685
crossref_primary_10_3390_ijerph19031525
crossref_primary_10_1007_s11628_024_00553_3
crossref_primary_10_12968_ijtr_2023_0063
crossref_primary_10_1371_journal_pone_0264368
crossref_primary_10_2196_42365
crossref_primary_10_1136_bmjopen_2023_076285
crossref_primary_10_31682_ayna_1208024
crossref_primary_10_1038_s41443_023_00766_6
crossref_primary_10_3389_frvir_2022_876433
crossref_primary_10_1016_j_chb_2024_108167
crossref_primary_10_2196_38413
crossref_primary_10_1007_s12144_024_07194_9
crossref_primary_10_2196_26292
crossref_primary_10_2196_29681
crossref_primary_10_1177_20438087221138716
crossref_primary_10_1007_s10942_023_00533_y
crossref_primary_10_1007_s12144_023_04485_5
crossref_primary_10_3389_fpsyt_2024_1467141
crossref_primary_10_1016_j_jvoice_2023_07_026
crossref_primary_10_1016_j_nsa_2024_104074
crossref_primary_10_1162_pres_a_00367
crossref_primary_10_1007_s10055_024_00998_x
crossref_primary_10_1007_s10639_023_12130_8
crossref_primary_10_1002_hsr2_816
crossref_primary_10_1016_j_compedu_2021_104384
crossref_primary_10_17759_exppsy_2022150204
crossref_primary_10_2196_48916
crossref_primary_10_3389_frvir_2024_1506938
crossref_primary_10_2196_48437
crossref_primary_10_3390_ijerph19169793
crossref_primary_10_1080_15401383_2023_2297854
Cites_doi 10.1162/pres.16.4.337
10.1016/j.chb.2010.01.010
10.1016/S0005-7967(01)00060-2
10.3389/fpsyg.2016.00326
10.1016/j.invent.2015.02.003
10.1016/j.chb.2019.06.015
10.1016/j.janxdis.2011.04.002
10.1037/a0026801
10.7326/0003-4819-150-10-200905190-02002
10.1037/a0033559
10.3389/fpsyg.2019.00176
10.1089/109493102321018187
10.1001/jamapsychiatry.2019.0219
10.18637/jss.v067.i01
10.1016/j.janxdis.2018.08.003
10.2196/17807
10.1016/j.brat.2019.04.004
10.1037/ccp0000333
10.1016/0005-7967(89)90113-7
10.1016/j.jbtep.2011.10.009
10.1016/j.janxdis.2018.07.003
10.1192/bjp.bp.116.193300
10.1080/16506070701421313
10.1001/archinte.166.10.1092
10.1371/journal.pone.0216288
10.7717/peerj.98
10.1177/1049731514568897
10.1001/archpsyc.1996.01830020087010
10.1007/s11920-017-0788-4
10.1371/journal.pone.0157503
10.1016/j.brat.2018.11.015
10.1002/da.20910
10.1080/16506073.2013.773062
10.1016/j.jsp.2013.11.003
10.1007/s10862-014-9454-x
10.1016/S1077-7229(03)80036-6
10.3389/fpsyt.2020.00116
10.1016/j.brat.2014.04.006
10.1016/j.brat.2015.08.010
10.1080/16506073.2017.1280843
10.1186/s13034-019-0307-y
10.1177/1049731510393984
10.1017/S0033291717001167
10.1089/cyber.2017.0174
10.3389/fpsyg.2019.02849
10.1016/j.invent.2016.09.006
10.3390/jcm8030309
10.3390/jpm10010014
10.1111/j.1749-6632.2010.05755.x
10.1016/j.brat.2010.07.009
10.1089/109493101300210231
10.1016/j.janxdis.2018.06.005
10.1080/16506073.2015.1126633
10.1016/j.janxdis.2008.11.007
10.1016/S2215-0366(18)30226-8
10.1089/cyber.2009.0398
10.1038/s41598-018-28113-6
10.3389/fpsyg.2019.00132
10.1891/0889-8391.30.2.77
10.1016/j.invent.2014.02.001
10.1046/j.1525-1497.2001.016009606.x
10.1016/j.brat.2018.07.003
10.1007/s00127-006-0143-2
10.1177/0145445509331926
10.3389/fpsyt.2019.00792
10.1016/0005-7967(96)00003-4
10.1016/j.paid.2016.01.026
ContentType Journal Article
Copyright 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020
2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution – Non-Commercial – No Derivatives License http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020
– notice: 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution – Non-Commercial – No Derivatives License http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 0YH
AAYXX
CITATION
NPM
K7.
7X8
ABXSW
ADTPV
AOWAS
D8T
DG8
ZZAVC
ABAVF
DG7
DOI 10.1080/16506073.2020.1795240
DatabaseName Taylor & Francis Open Access
CrossRef
PubMed
ProQuest Criminal Justice (Alumni)
MEDLINE - Academic
SWEPUB Linköpings universitet full text
SwePub
SwePub Articles
SWEPUB Freely available online
SWEPUB Linköpings universitet
SwePub Articles full text
SWEPUB Stockholms universitet full text
SWEPUB Stockholms universitet
DatabaseTitle CrossRef
PubMed
ProQuest Criminal Justice (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

ProQuest Criminal Justice (Alumni)

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 0YH
  name: Taylor & Francis Open Access
  url: https://www.tandfonline.com
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Psychology
EISSN 1651-2316
EndPage 87
ExternalDocumentID oai_swepub_ki_se_468523
oai_DiVA_org_su_186245
oai_DiVA_org_liu_170067
32870126
10_1080_16506073_2020_1795240
1795240
Genre Research Article
Journal Article
GroupedDBID ---
.7I
.QK
0BK
0R~
0YH
29F
2DF
36B
4.4
53G
5GY
5VS
AAGZJ
AAMFJ
AAMIU
AAPUL
AATTQ
AAZMC
ABCCY
ABDBF
ABFIM
ABIVO
ABJNI
ABLIJ
ABPEM
ABTAI
ABXUL
ABXYU
ABZLS
ACGEJ
ACGFS
ACHQT
ACTIO
ACTOA
ACUHS
ADAHI
ADCVX
ADKVQ
ADXPE
AECIN
AEISY
AEKEX
AEMXT
AEOZL
AEPSL
AEYOC
AEZRU
AGDLA
AGMYJ
AGRBW
AHDZW
AIJEM
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AVBZW
AWYRJ
BEJHT
BLEHA
BMOTO
BOHLJ
CCCUG
CQ1
CS3
DGFLZ
DKSSO
DU5
EAP
EBD
EBS
EMB
EMK
EMOBN
EPL
EPS
ESX
E~B
E~C
F5P
FEDTE
G-F
GTTXZ
H13
HF~
HVGLF
HZ~
IPNFZ
J.O
KSSTO
KYCEM
LJTGL
M4Z
NA5
O9-
PQQKQ
RIG
RNANH
ROSJB
RSYQP
S-F
STATR
SV3
TBQAZ
TDBHL
TEH
TFH
TFL
TFW
TNJ
TNTFI
TRJHH
TUROJ
TUS
UT5
UT9
VAE
~01
~S~
AAGDL
AAHIA
AAYXX
ADYSH
AEFOU
AFRVT
AIYEW
AMPGV
CITATION
AAIFK
ABITY
ABLUQ
ABYAV
AFUSO
CAG
COF
DAOCQ
DTEEQ
DYOWO
EJD
NPM
PPYGK
K7.
TASJS
7X8
AACLK
ABXSW
ADTPV
AIQFI
AOWAS
D8T
DG8
ZZAVC
ABAVF
DG7
ID FETCH-LOGICAL-c554t-cef5673ce4d9ae16cf87ca7af77379b35d6da8f77ebee94954af7b27c02e0193
IEDL.DBID 0YH
ISSN 1650-6073
1651-2316
IngestDate Mon Aug 25 03:34:33 EDT 2025
Thu Aug 21 06:21:59 EDT 2025
Thu Aug 21 06:40:35 EDT 2025
Fri Jul 11 06:21:48 EDT 2025
Sat Jul 26 02:13:33 EDT 2025
Wed Feb 19 02:29:16 EST 2025
Tue Jul 01 01:15:09 EDT 2025
Thu Apr 24 22:59:22 EDT 2025
Wed Dec 25 09:07:39 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords effectiveness
exposure therapy
Fear of public speaking
Glossophobia
Virtual Reality
Language English
License open-access: http://creativecommons.org/licenses/by-nc-nd/4.0/: http://creativecommons.org/licenses/by-nc-nd/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c554t-cef5673ce4d9ae16cf87ca7af77379b35d6da8f77ebee94954af7b27c02e0193
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ORCID 0000-0002-2172-8813
0000-0003-0482-9521
0000-0002-9125-8060
0000-0003-4753-6745
0000-0001-5879-2168
0000-0002-3061-501X
0000-0002-5136-212X
OpenAccessLink https://www.tandfonline.com/doi/abs/10.1080/16506073.2020.1795240
PMID 32870126
PQID 2476544012
PQPubID 186210
PageCount 21
ParticipantIDs swepub_primary_oai_swepub_ki_se_468523
pubmed_primary_32870126
swepub_primary_oai_DiVA_org_liu_170067
proquest_miscellaneous_2439630073
crossref_primary_10_1080_16506073_2020_1795240
proquest_journals_2476544012
informaworld_taylorfrancis_310_1080_16506073_2020_1795240
swepub_primary_oai_DiVA_org_su_186245
crossref_citationtrail_10_1080_16506073_2020_1795240
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – year: 2021
  text: 2021
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Abingdon
PublicationTitle Cognitive behaviour therapy
PublicationTitleAlternate Cogn Behav Ther
PublicationYear 2021
Publisher Routledge
Taylor & Francis Ltd
Publisher_xml – name: Routledge
– name: Taylor & Francis Ltd
References cit0033
cit0031
cit0075
cit0030
cit0071
cit0072
cit0070
cit0039
cit0037
cit0038
cit0035
cit0036
cit0022
cit0066
cit0023
cit0067
cit0020
cit0021
cit0065
cit0062
cit0063
cit0060
cit0061
cit0028
cit0029
cit0026
cit0027
cit0024
cit0068
cit0025
cit0069
cit0011
cit0055
cit0012
cit0056
cit0053
cit0010
cit0054
cit0051
cit0052
cit0050
Kuznetsova A. (cit0032) 2017
cit0019
Wang P. S. (cit0073) 2007; 6
cit0017
cit0018
cit0015
cit0059
cit0016
Wechsler T. F. (cit0074) 2019
cit0013
cit0057
cit0014
cit0058
Sheehan D. (cit0064) 1998; 59
Lindner P. (cit0034) 2016; 6073
cit0044
cit0001
cit0045
cit0042
cit0043
cit0040
cit0041
Oh C. (cit0048) 2018
Mörtberg E. (cit0046) 2013
cit0008
cit0009
cit0006
cit0007
cit0004
cit0005
cit0049
cit0002
cit0003
cit0047
References_xml – ident: cit0063
  doi: 10.1162/pres.16.4.337
– ident: cit0022
  doi: 10.1016/j.chb.2010.01.010
– ident: cit0004
  doi: 10.1016/S0005-7967(01)00060-2
– ident: cit0053
  doi: 10.3389/fpsyg.2016.00326
– ident: cit0023
  doi: 10.1016/j.invent.2015.02.003
– ident: cit0033
  doi: 10.1016/j.chb.2019.06.015
– ident: cit0011
  doi: 10.1016/j.janxdis.2011.04.002
– ident: cit0061
  doi: 10.1037/a0026801
– ident: cit0075
  doi: 10.7326/0003-4819-150-10-200905190-02002
– ident: cit0002
  doi: 10.1037/a0033559
– ident: cit0040
  doi: 10.3389/fpsyg.2019.00176
– ident: cit0021
  doi: 10.1089/109493102321018187
– ident: cit0014
  doi: 10.1001/jamapsychiatry.2019.0219
– ident: cit0006
  doi: 10.18637/jss.v067.i01
– ident: cit0010
  doi: 10.1016/j.janxdis.2018.08.003
– ident: cit0041
  doi: 10.2196/17807
– start-page: 82
  year: 2017
  ident: cit0032
  publication-title: Journal of Statistical Software
– ident: cit0043
  doi: 10.1016/j.brat.2019.04.004
– ident: cit0042
  doi: 10.1037/ccp0000333
– ident: cit0051
  doi: 10.1016/0005-7967(89)90113-7
– ident: cit0013
  doi: 10.1016/j.jbtep.2011.10.009
– start-page: 1
  year: 2013
  ident: cit0046
  publication-title: Psychology and Psychotherapy
– ident: cit0037
  doi: 10.1016/j.janxdis.2018.07.003
– ident: cit0019
  doi: 10.1192/bjp.bp.116.193300
– ident: cit0027
  doi: 10.1080/16506070701421313
– ident: cit0065
  doi: 10.1001/archinte.166.10.1092
– ident: cit0069
  doi: 10.1371/journal.pone.0216288
– start-page: 1
  year: 2018
  ident: cit0048
  publication-title: Frontiers in Robotics AI TBA
– ident: cit0028
  doi: 10.7717/peerj.98
– ident: cit0054
  doi: 10.1177/1049731514568897
– ident: cit0067
  doi: 10.1001/archpsyc.1996.01830020087010
– ident: cit0009
  doi: 10.1007/s11920-017-0788-4
– ident: cit0059
  doi: 10.1371/journal.pone.0157503
– ident: cit0030
  doi: 10.1016/j.brat.2018.11.015
– ident: cit0050
  doi: 10.1002/da.20910
– ident: cit0049
  doi: 10.1080/16506073.2013.773062
– ident: cit0044
  doi: 10.1016/j.jsp.2013.11.003
– ident: cit0052
  doi: 10.1007/s10862-014-9454-x
– ident: cit0001
  doi: 10.1016/S1077-7229(03)80036-6
– start-page: 10
  year: 2019
  ident: cit0074
  publication-title: Frontiers in Psychology
– ident: cit0036
  doi: 10.3389/fpsyt.2020.00116
– ident: cit0012
  doi: 10.1016/j.brat.2014.04.006
– ident: cit0045
  doi: 10.1016/j.brat.2015.08.010
– ident: cit0039
  doi: 10.1080/16506073.2017.1280843
– ident: cit0029
  doi: 10.1186/s13034-019-0307-y
– ident: cit0025
  doi: 10.1177/1049731510393984
– ident: cit0024
  doi: 10.1017/S0033291717001167
– ident: cit0068
  doi: 10.1089/cyber.2017.0174
– ident: cit0060
  doi: 10.3389/fpsyg.2019.02849
– ident: cit0071
  doi: 10.1016/j.invent.2016.09.006
– volume: 6
  start-page: 177
  issue: 3
  year: 2007
  ident: cit0073
  publication-title: World Psychiatry
– ident: cit0020
  doi: 10.3390/jcm8030309
– ident: cit0026
  doi: 10.3390/jpm10010014
– ident: cit0057
  doi: 10.1111/j.1749-6632.2010.05755.x
– ident: cit0003
  doi: 10.1016/j.brat.2010.07.009
– ident: cit0018
  doi: 10.1089/109493101300210231
– ident: cit0015
  doi: 10.1016/j.janxdis.2018.06.005
– ident: cit0047
  doi: 10.1080/16506073.2015.1126633
– ident: cit0066
  doi: 10.1001/archpsyc.1996.01830020087010
– ident: cit0007
  doi: 10.1016/j.janxdis.2008.11.007
– ident: cit0017
  doi: 10.1016/S2215-0366(18)30226-8
– ident: cit0062
  doi: 10.1089/cyber.2009.0398
– ident: cit0016
  doi: 10.1038/s41598-018-28113-6
– ident: cit0038
  doi: 10.3389/fpsyg.2019.00132
– ident: cit0008
  doi: 10.1891/0889-8391.30.2.77
– ident: cit0058
  doi: 10.1016/j.invent.2014.02.001
– ident: cit0031
  doi: 10.1046/j.1525-1497.2001.016009606.x
– ident: cit0056
  doi: 10.1016/j.brat.2018.07.003
– ident: cit0070
  doi: 10.1007/s00127-006-0143-2
– ident: cit0072
  doi: 10.1177/0145445509331926
– ident: cit0035
  doi: 10.3389/fpsyt.2019.00792
– volume: 6073
  start-page: 1
  year: 2016
  ident: cit0034
  publication-title: Cognitive Behaviour Therapy
– ident: cit0055
  doi: 10.1016/0005-7967(96)00003-4
– volume: 59
  year: 1998
  ident: cit0064
  publication-title: The Journal of Clinical Psychiatry
– ident: cit0005
  doi: 10.1016/j.paid.2016.01.026
SSID ssj0020842
Score 2.4543862
Snippet Virtual Reality (VR) can be used as a therapeutic tool to conduct efficacious in-session exposure therapy by presenting virtual equivalents of phobic stimuli,...
SourceID swepub
proquest
pubmed
crossref
informaworld
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 67
SubjectTerms Anxiety
effectiveness
exposure therapy
Fear of public speaking
Glossophobia
Psychology
psykologi
Public speaking
Virtual Reality
Title Virtual Reality exposure therapy for public speaking anxiety in routine care: a single-subject effectiveness trial
URI https://www.tandfonline.com/doi/abs/10.1080/16506073.2020.1795240
https://www.ncbi.nlm.nih.gov/pubmed/32870126
https://www.proquest.com/docview/2476544012
https://www.proquest.com/docview/2439630073
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-170067
https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-186245
http://kipublications.ki.se/Default.aspx?queryparsed=id:144557803
Volume 50
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagvXBBIF6BUhkJuAUSPxNuK0q1QoIDKuVxsRzHrlasklWyK7X_vjPOQxQVeuCWxB4nytieh2e-IeQlZlcKDNXhTtap4E6l1tYuLVjl88BCqXJMTv70WS2_io_f5RRN2I9hlWhDhwEoIu7VuLht1U8RcW9zhah4moN1x-CRLiWIpdtkHyRxhkUMsh_L2ebKilg_B0lSpJmSeP42zBXxdAW89DoV9A980SiTju-Ru6MySRcD9--TW755QLrTVYdJIfSLjzo29eebFv2AdMi1uqDwNjrAW9N-42M5Kmqbc4zepKuGdi1MxsZTDAp7Ry1Fb8Lap_2uQp8NHSJAxk2SxqofD8nJ8YeT98t0rKyQOlAftqnzQSrNnRd1aX2uXCi0s9oGrbkuKy5rVdsC7oDFvgQbSkBTxbTLmAedkD8ie03b-CeE5sxlMqtA7AstLGxZNQwpKs8UCzzIkBAx_U_jRtRxLH6xNvkITjqxwSAbzMiGhLyZyTYD7MZNBOXvzDLb6O8IQ3ESw2-gPZg4a8YV3BsmtJICrE-WkBdzM6w9PFCxjW932IeXCFmmeUIeDzNi_lqOJ8g5Uwl5PUyRuQUBvY9WpwvTdmdmvdoZhEhUOiGv_tWxh36YzCOvH3B89AuuvBGqkIw__Y9f8ozcYRi8E31NB2Rv2-38c9C-ttVhXF-HZH-xPPr57RKmoyc2
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZge4ALD_EKLWAk4JZl42fCrQKqpbQ9VEvVm-U4Nlp1layyidTy6_HESdRWhR56S2yPFTtje2Y88w1CHyC6koGrDjW8iBk1Ita6MHFKcps44jKRQHDy4ZGY_2L7p_z0UiwMuFWCDu0CUES3V8PiBmP04BL3OREAiyepV--IL5IZ9-fSfbTFM0bTCdpaHO_P56PaNUu7FDpAFAPVEMfzr46unFBX8EtvkkKvQYx2x9LeY2SGAQVvlLNp2-RT8-ca1uPdRvwEPeqlVrwb2OwpumfLZ6g-WdYQfYKPbSfMY3u-rsDgiENQ1wX2Y8IBRxtv1rbLe4V1eQ5uonhZ4rryXF9aDN5nX7DGYLZY2XjT5mAcwsHVpN-NcZde5Dla7H1ffJ3HfQqH2Hg5pYmNdVxIaiwrMm0TYVwqjZbaSUllllNeiEKn_s3zks28ssZ8VU6kmRHrhU_6Ak3KqrSvEE6ImfFZ7uULJpn2e2Phu2S5JYI46riLEBv-mjI9vDlk2VippEdBHeZQwRyqfg4jNB3J1gHf4zaC7DJLqKYzrLiQBUXRW2h3Bv5R_VaxUYRJwZlXc0mE3o_VfpHDzY0ubdVCG5oBNpqkEXoZ-G78WgpX1QkREfoUGHGsAeTwb8uTXVXVv9Vq2SrAYhQyQh__13Dj20HUEL-5w77ozD9ZxUTKCX19hyl5hx7MF4cH6uDH0c9t9JCAx1Bn4NpBk6Zu7Rsv8jX5235N_wXCpUqq
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELegkxAvDMRX2AAjAW8pjT8T3iZGVQZMaCoTb5bj2KhalVT5kAZ_Pb44qdg02MPe2thn1e7Zvrv87ncIvYbsSgZQHWp4ETNqRKx1YeKU5DZxxGUigeTkr8di8Z0d_eAjmrAZYJXgQ7tAFNGf1bC5N4UbEXHvEgGseJJ67474RzLj_lq6jXYE0OFN0M7y5Gix2Hpds7SvoANCMUiNaTz_GujCBXWBvvQqI_QSw2h_K813UT7OJ4BRzqZdm0_N70tUjzea8H10b7BZ8UFQsgfoli0fovp0VUPuCT6xvSmP7fmmgnAjDildv7CfEg4s2rjZ2L7qFdblOYBE8arEdeV1vrQYsGfvscYQtFjbuOlyCA3hADQZzmLcFxd5hJbzj8sPi3go4BAbb6W0sbGOC0mNZUWmbSKMS6XRUjspqcxyygtR6NR_85pkM--qMd-UE2lmxHrTkz5Gk7Iq7VOEE2JmfJZ764JJpv3JWPghWW6JII467iLExj9NmYHcHGpsrFUycKCOa6hgDdWwhhGabsU2gd3jOoHsb41QbR9WcaEGiqLXyO6P6qOGg6JRhEnBmXdySYRebZv9Fof3Nrq0VQd9aAbMaJJG6ElQu-2vpfCiOiEiQm-DHm5bgDf8cHV6oKr6p1qvOgVMjEJG6M3_Oja-H-QM8asHHB6d-U9WMZFyQp_dYEleojvfDufqy6fjz3voLgG4UB_d2keTtu7sc2_vtfmLYUf_AXHySU4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Virtual+Reality+exposure+therapy+for+public+speaking+anxiety+in+routine+care%3A+a+single-subject+effectiveness+trial&rft.jtitle=Cognitive+behaviour+therapy&rft.au=Lindner%2C+P&rft.au=Dagoo%2C+J&rft.au=Hamilton%2C+W&rft.au=Miloff%2C+A&rft.date=2021&rft.issn=1650-6073&rft.volume=50&rft.issue=1&rft.spage=67&rft_id=info:doi/10.1080%2F16506073.2020.1795240&rft.externalDocID=oai_swepub_ki_se_468523
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1650-6073&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1650-6073&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1650-6073&client=summon